SE421698B - Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno (2,3-c) pyridinderivat - Google Patents
Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno (2,3-c) pyridinderivatInfo
- Publication number
- SE421698B SE421698B SE7607201A SE7607201A SE421698B SE 421698 B SE421698 B SE 421698B SE 7607201 A SE7607201 A SE 7607201A SE 7607201 A SE7607201 A SE 7607201A SE 421698 B SE421698 B SE 421698B
- Authority
- SE
- Sweden
- Prior art keywords
- tieno
- tetrahydro
- preparing
- procedure
- pyridine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7520241A FR2315274A1 (fr) | 1975-06-27 | 1975-06-27 | Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications |
Publications (2)
Publication Number | Publication Date |
---|---|
SE7607201L SE7607201L (sv) | 1976-12-28 |
SE421698B true SE421698B (sv) | 1982-01-25 |
Family
ID=9157178
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7607201A SE421698B (sv) | 1975-06-27 | 1976-06-23 | Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno (2,3-c) pyridinderivat |
Country Status (26)
Country | Link |
---|---|
US (1) | US4075340A (fr) |
JP (1) | JPS607633B2 (fr) |
AR (1) | AR211777A1 (fr) |
AT (1) | AT347950B (fr) |
BE (1) | BE843402A (fr) |
CA (1) | CA1071635A (fr) |
CH (1) | CH596169A5 (fr) |
DD (1) | DD125080A5 (fr) |
DE (1) | DE2628045A1 (fr) |
DK (1) | DK279976A (fr) |
ES (1) | ES449191A1 (fr) |
FR (1) | FR2315274A1 (fr) |
GB (1) | GB1492239A (fr) |
GR (1) | GR60042B (fr) |
HU (1) | HU172697B (fr) |
IE (1) | IE43915B1 (fr) |
IL (1) | IL49702A (fr) |
LU (1) | LU75230A1 (fr) |
MX (1) | MX3565E (fr) |
NL (1) | NL183032C (fr) |
PL (1) | PL105962B1 (fr) |
PT (1) | PT65271B (fr) |
SE (1) | SE421698B (fr) |
SU (1) | SU628820A3 (fr) |
YU (1) | YU39480B (fr) |
ZA (1) | ZA763270B (fr) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4127580A (en) * | 1975-02-07 | 1978-11-28 | Parcor | Process for the preparation of thieno-pyridine derivatives |
FR2395271A1 (fr) * | 1977-06-21 | 1979-01-19 | Parcor | Procede de preparation de thieno (2,3-c) et thieno (3,2-c) pyridines |
GB2038625B (en) * | 1978-12-29 | 1983-01-12 | Parcor | Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity |
US4749692A (en) * | 1977-06-22 | 1988-06-07 | Sanofi, S.A. | Therapeutic compositions having anti-thrombotic and anti-blood-platelet-aggregating activity |
FR2397417A1 (fr) * | 1977-07-12 | 1979-02-09 | Parcor | Procede de preparation de derives de la thienopyridine |
AT368504B (de) * | 1977-10-15 | 1982-10-25 | Boehringer Sohn Ingelheim | Verfahren zur herstellung neuer 4-phenyl-thieno- (2,3-c)-piperidine |
US4321266A (en) * | 1980-10-06 | 1982-03-23 | Sanofi | 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-C] pyridine |
FR2508453A1 (fr) * | 1981-06-30 | 1982-12-31 | Sanofi Sa | Procede de preparation de derives des (thienyl-2)- et thienyl-3)-2 ethylamines et produits ainsi obtenus |
US4547514A (en) * | 1983-12-05 | 1985-10-15 | A. H. Robins Company, Incorporated | Aryloxy-N-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activity |
DE3736664A1 (de) * | 1987-10-29 | 1989-05-11 | Boehringer Ingelheim Kg | Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung |
US5294621A (en) * | 1992-10-07 | 1994-03-15 | Ortho Pharmaceutical Corporation | Thieno tetrahydropyridines useful as class III antiarrhythmic agents |
WO2000000472A1 (fr) * | 1998-06-30 | 2000-01-06 | Du Pont Pharmaceuticals Company | Antagonistes du recepteur 5-ht¿7? |
US6090797A (en) * | 1998-09-02 | 2000-07-18 | Novo Nordisk A/S | 4,5,6,7-tetrahydro-thieno(2,3-C)pyridine derivatives |
AU5154699A (en) * | 1998-09-02 | 2000-03-27 | Novo Nordisk A/S | 4,5,6,7-tetrahydro-thieno(2,3-c)pyridine derivatives |
US8914114B2 (en) | 2000-05-23 | 2014-12-16 | The Feinstein Institute For Medical Research | Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation |
CA2476896A1 (fr) * | 2002-02-26 | 2003-09-04 | North Shore-Long Island Jewish Research Institute | Inhibition de la production d'une cytokine inflammatoire par la stimulation de recepteurs muscariniques cerebraux |
US10912712B2 (en) | 2004-03-25 | 2021-02-09 | The Feinstein Institutes For Medical Research | Treatment of bleeding by non-invasive stimulation |
WO2005092308A2 (fr) | 2004-03-25 | 2005-10-06 | The Feinstein Institute For Medical Research | Garrot neural |
EP2298410B1 (fr) | 2004-12-27 | 2013-10-09 | The Feinstein Institute for Medical Research | Traitement des troubles inflammatoires par la stimulation électrique du nerf vague |
US11207518B2 (en) | 2004-12-27 | 2021-12-28 | The Feinstein Institutes For Medical Research | Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway |
WO2009029614A1 (fr) | 2007-08-27 | 2009-03-05 | The Feinstein Institute For Medical Research | Dispositifs et procédés permettant d'inhiber l'activation de granulocytes par stimulation neurale |
US9662490B2 (en) | 2008-03-31 | 2017-05-30 | The Feinstein Institute For Medical Research | Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug |
WO2009146030A1 (fr) | 2008-03-31 | 2009-12-03 | The Feinstein Institute For Medical Research | Méthodes et systèmes de réduction d’une inflammation par neuromodulation de l’activité des lymphocytes t |
EP2355893B1 (fr) | 2008-11-18 | 2013-12-25 | Setpoint Medical Corporation | Dispositifs permettant d'optimiser la pose d'une électrode pour stimulation anti-inflammatoire |
US8996116B2 (en) | 2009-10-30 | 2015-03-31 | Setpoint Medical Corporation | Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction |
US9211410B2 (en) | 2009-05-01 | 2015-12-15 | Setpoint Medical Corporation | Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation |
EP2440284B1 (fr) | 2009-06-09 | 2018-09-12 | Setpoint Medical Corporation | Manchon pour nerf muni d'une poche pour stimulateur sans fil |
WO2014169145A1 (fr) | 2013-04-10 | 2014-10-16 | Setpoint Medical Corporation | Stimulation de nerf vague en boucle fermée |
US9833621B2 (en) | 2011-09-23 | 2017-12-05 | Setpoint Medical Corporation | Modulation of sirtuins by vagus nerve stimulation |
EP3636314B1 (fr) | 2009-12-23 | 2021-09-08 | Setpoint Medical Corporation | Dispositifs et systèmes de stimulation neuronale pour le traitement de l'inflammation chronique |
EP2707094B1 (fr) | 2011-05-09 | 2016-02-03 | Setpoint Medical Corporation | Activation d'impulsions uniques de la voie anti-inflammatoire cholinergique pour traiter l'inflammation chronique |
AU2013235487B2 (en) | 2012-03-23 | 2017-09-07 | Memorial Sloan-Kettering Cancer Center | Treatment of pancreatic and related cancers with 5-acyl-6,7-dihydrothieno[3,2-c]pyridines |
US9572983B2 (en) | 2012-03-26 | 2017-02-21 | Setpoint Medical Corporation | Devices and methods for modulation of bone erosion |
US10011585B2 (en) | 2014-07-28 | 2018-07-03 | Merck Sharp & Dohme Corp. | Factor XIa inhibitors |
US11311725B2 (en) | 2014-10-24 | 2022-04-26 | Setpoint Medical Corporation | Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation |
WO2016126807A1 (fr) | 2015-02-03 | 2016-08-11 | Setpoint Medical Corporation | Appareil et procédé de rappel, d'incitation ou d'alerte d'un patient ayant un stimulateur implanté |
US10596367B2 (en) | 2016-01-13 | 2020-03-24 | Setpoint Medical Corporation | Systems and methods for establishing a nerve block |
US10695569B2 (en) | 2016-01-20 | 2020-06-30 | Setpoint Medical Corporation | Control of vagal stimulation |
EP3405255A4 (fr) | 2016-01-20 | 2019-10-16 | Setpoint Medical Corporation | Microstimulateurs implantables et systèmes de recharge par induction |
US11471681B2 (en) | 2016-01-20 | 2022-10-18 | Setpoint Medical Corporation | Batteryless implantable microstimulators |
US10583304B2 (en) | 2016-01-25 | 2020-03-10 | Setpoint Medical Corporation | Implantable neurostimulator having power control and thermal regulation and methods of use |
WO2019036470A1 (fr) | 2017-08-14 | 2019-02-21 | Setpoint Medical Corporation | Test de dépistage pour stimulation du nerf vague |
US11260229B2 (en) | 2018-09-25 | 2022-03-01 | The Feinstein Institutes For Medical Research | Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation |
KR20230012585A (ko) | 2020-05-21 | 2023-01-26 | 더 파인스타인 인스티튜츠 포 메디칼 리서치 | 미주 신경 자극을 위한 시스템들 및 방법들 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2215948B1 (fr) * | 1973-02-01 | 1976-05-14 | Centre Etd Ind Pharma |
-
1975
- 1975-06-27 FR FR7520241A patent/FR2315274A1/fr active Granted
-
1976
- 1976-05-17 CH CH612276A patent/CH596169A5/xx not_active IP Right Cessation
- 1976-05-31 IE IE1149/76A patent/IE43915B1/en unknown
- 1976-06-01 IL IL49702A patent/IL49702A/xx unknown
- 1976-06-01 GR GR50863A patent/GR60042B/el unknown
- 1976-06-02 US US05/692,186 patent/US4075340A/en not_active Expired - Lifetime
- 1976-06-02 ZA ZA763270A patent/ZA763270B/xx unknown
- 1976-06-14 SU SU762367256A patent/SU628820A3/ru active
- 1976-06-15 YU YU1462/76A patent/YU39480B/xx unknown
- 1976-06-17 NL NLAANVRAGE7606574,A patent/NL183032C/xx not_active IP Right Cessation
- 1976-06-21 CA CA255,299A patent/CA1071635A/fr not_active Expired
- 1976-06-22 DK DK279976A patent/DK279976A/da unknown
- 1976-06-23 SE SE7607201A patent/SE421698B/xx not_active IP Right Cessation
- 1976-06-23 DE DE19762628045 patent/DE2628045A1/de not_active Ceased
- 1976-06-24 PT PT65271A patent/PT65271B/fr unknown
- 1976-06-24 AT AT461776A patent/AT347950B/de not_active IP Right Cessation
- 1976-06-24 AR AR263737A patent/AR211777A1/es active
- 1976-06-24 LU LU75230A patent/LU75230A1/xx unknown
- 1976-06-25 ES ES449191A patent/ES449191A1/es not_active Expired
- 1976-06-25 HU HU76PA00001254A patent/HU172697B/hu not_active IP Right Cessation
- 1976-06-25 MX MX76799U patent/MX3565E/es unknown
- 1976-06-25 GB GB26591/76A patent/GB1492239A/en not_active Expired
- 1976-06-25 BE BE168304A patent/BE843402A/fr not_active IP Right Cessation
- 1976-06-25 DD DD193581A patent/DD125080A5/xx unknown
- 1976-06-26 PL PL1976190741A patent/PL105962B1/pl unknown
- 1976-06-26 JP JP51075943A patent/JPS607633B2/ja not_active Expired
Also Published As
Publication number | Publication date |
---|---|
PL105962B1 (pl) | 1979-11-30 |
AT347950B (de) | 1979-01-25 |
NL183032C (nl) | 1988-07-01 |
IL49702A (en) | 1979-01-31 |
ATA461776A (de) | 1978-06-15 |
JPS525793A (en) | 1977-01-17 |
IE43915B1 (en) | 1981-07-01 |
FR2315274B1 (fr) | 1979-08-10 |
ZA763270B (en) | 1977-05-25 |
IE43915L (en) | 1976-12-27 |
FR2315274A1 (fr) | 1977-01-21 |
GR60042B (en) | 1978-04-01 |
ES449191A1 (es) | 1977-12-01 |
DD125080A5 (fr) | 1977-03-30 |
PT65271B (fr) | 1977-12-10 |
PT65271A (fr) | 1976-07-01 |
BE843402A (fr) | 1976-12-27 |
GB1492239A (en) | 1977-11-16 |
DE2628045A1 (de) | 1977-01-20 |
AR211777A1 (es) | 1978-03-15 |
AU1537576A (en) | 1978-01-05 |
JPS607633B2 (ja) | 1985-02-26 |
CA1071635A (fr) | 1980-02-12 |
SE7607201L (sv) | 1976-12-28 |
SU628820A3 (ru) | 1978-10-15 |
MX3565E (es) | 1981-03-13 |
NL7606574A (nl) | 1976-12-29 |
LU75230A1 (fr) | 1977-02-18 |
HU172697B (hu) | 1978-11-28 |
CH596169A5 (fr) | 1978-02-28 |
NL183032B (nl) | 1988-02-01 |
DK279976A (da) | 1976-12-28 |
IL49702A0 (en) | 1976-08-31 |
US4075340A (en) | 1978-02-21 |
YU39480B (en) | 1984-12-31 |
YU146276A (en) | 1982-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE421698B (sv) | Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno (2,3-c) pyridinderivat | |
SE421623B (sv) | Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno(2,3-c respektive 3,2-c)-pyridinderivat | |
SE434049B (sv) | Forfarande for framstellning av 1,4-dihydropyridinderivat | |
SE416203B (sv) | Forfarande for framstellning av 4,5,6,7-tetrahydro-furo (respektive - tieno)-(3,2-c)pyridinderivat | |
SE429970B (sv) | Forfarande for framstellning av glukopyranosido-1,6-mannit | |
SE432928B (sv) | Forfarande for framstellning 4,5,6-trinor-3,7-inter-m-fenylen-pge, och vissa derivat derav | |
SE421795B (sv) | Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno(3,2-c)pyridin-derivat | |
SE7808059L (sv) | Forfarande for framstellning av 1,2,4-triazin-5-on-derivat | |
SE428684B (sv) | Analogiforfarande for framstellning av substituerade (3-lagalkylamino-2-hydroxi-propoxi)pyridiner | |
PL191674A1 (pl) | Sposob wytwarzania nowych pochodnych tiazolo(3,4-b)izochinoliny | |
SE433745B (sv) | Forfarande for framstellning av tetrahydroisokinolinderivat | |
DK360576A (da) | Fremgangsmade til fremstilling af pyridinderivater | |
SE423390B (sv) | Foerfarande foer framstaellning av eburnameninderivat | |
SE439631B (sv) | Forfarande for framstellning av 3,4-dihydrokarbostyrilderivat | |
SE423902B (sv) | Forfarande for framstellning av purinderivat | |
SE421622B (sv) | Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno(3,2-c)-pyridinderivat | |
SE422579B (sv) | Forfarande for framstellning av 4-oxo-hexahydro-pyrazino(2,1-a)isokinolinderivat | |
SE422324B (sv) | Forfarande for framstellning av 3,4-dihydro-2(1h)-kinazolinderivat | |
SE421529B (sv) | Forfarande for framstellning av tieno(3,2-c)pyridin-derivat | |
SE426585B (sv) | Forfarande for framstellning av vissa aminoalkylbicyklo (2.2.2) oktanderivat | |
SE421700B (sv) | Forfarande for framstellning av 2-alkoxikarbonyl-4,5,6,7-tetrahydrotieno(3,2-c)pyridinderivat | |
AR211854A1 (es) | Procedimiento de preparacion de derivados polisustituidos de 10-piperazinodibenzo(b,f)tiepina | |
SE421699B (sv) | Forfarande for framstellning av 4,5,6,7-tetrahydro-tieno(3,2-c respektive 2,3-c)-pyridinderivat | |
SE419222B (sv) | Forfarande for framstellning av derivat av oxatiino (1,4)(2,3-c) pyrrol | |
NL181432C (nl) | Werkwijze ter bereiding van 4,5,6,7-tetrahydrothieno(3,2-c)pyridinederivaten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NUG | Patent has lapsed |
Ref document number: 7607201-6 Effective date: 19940110 Format of ref document f/p: F |